English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduUCI Health, the clinical enterprise of the University of California, Irvine, has completed the acquisition of four hospitals and associated outpatient locations from Tenet Healthcare Corporation.
Tag: UCI Health
UCI launches innovative initiative to address diabetes in the Latinx community
Orange, Calif. — The University of California, Irvine has launched an initiative to address the toll diabetes takes on Orange County’s Latinx community and ensure greater well-being for a population that is disproportionately affected by the disease.
UCI receives $580 million in research funding for fiscal 2021-22
Irvine, Calif., Aug. 25, 2022 — From monitoring sandy beaches to gauge the effects of sea-level rise to holding clinical trials for potentially lifesaving cancer treatments, scholars, scientists and physicians at the University of California, Irvine are blazing new paths to help change the world. And their impact keeps growing.
Precision health perspectives
In February, UCI launched the Institute for Precision Health, a campus-wide, interdisciplinary endeavor that merges UCI’s powerhouse health sciences, engineering, machine learning, artificial intelligence, clinical genomics and data science capabilities. The objective is to identify, create and deliver the most effective health and wellness strategy for each individual person and, in doing so, confront the linked challenges of health equity and the high cost of care.
Joe C. Wen and family donate $20 million to support the new UCI Health Center for Advanced Care
Irvine, Calif., June 27, 2022 — Supported by a $20 million gift from Joe C. Wen and his family, the UCI Health outpatient clinical facility at the new UCI Health–Irvine complex will bring specialty clinical expertise closer to coastal and south Orange County residents on the UCI campus. “The Joe C. Wen & Family Center for Advanced Care at UCI Health–Irvine will play a special role in the life of south Orange County because of our unique ability to marshal all the resources of a comprehensive research university in support of delivering the best and most up-to-date care,” said UCI Chancellor Howard Gillman.
Falling Leaves Foundation $30 million lead gift to fund innovative UCI medical research building
Irvine, Calif., Sept. 20, 2021 — Supported by a $30 million lead gift from the Falling Leaves Foundation, a planned state-of-the-art medical research facility at the University of California, Irvine will expand the global reach and impact of the campus’s advanced cross-disciplinary teaching and translational research achievements.
What you need to know about the delta variant
For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he’s one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal mutation of the virus, called the delta variant, sparks another wave of cases, he offers his expertise about this threat.
UCI receives record $592 million in research funding for fiscal 2020-21
Irvine, Calif., Aug. 2, 2021 — From cutting-edge research for advancing precision medicine to an innovative new effort for improving public water infrastructure to increase conservation, University of California, Irvine scholars, scientists and physicians are blazing new paths to help change the world. And their impact keeps growing.
Chao family gifts to UCI Health for cancer care top $50 million
Orange, Calif., June 1, 2021 — With its current gift, longtime UCI Health benefactor the Chao family has committed $50 million since 1995 to UCI Health toward advancing cancer care in Orange County and beyond. The family’s latest gift will name the cancer center at the new UCI Medical Center in Irvine, expanding access to leading-edge cancer treatments and therapies, promising clinical trials, and world-class cancer care driven by the latest in precision medicine.
UCI to build world-class hospital on Irvine campus
Irvine, Calif., Jan. 21, 2021 — Plans to build a world-class, acute care hospital on the northern edge of the University of California, Irvine academic campus advanced significantly today, as the University of California Board of Regents granted approval of the project’s 144-bed acute care facility, ambulatory care center and cancer center.
New UCI Health Center for Advanced Care to provide greater access to world-class care
Irvine, Calif., Aug. 13, 2020 — The University of California, Irvine is bringing world-class healthcare services to coastal and southern Orange County with plans to build the UCI Health Center for Advanced Care, which will be home to the Center for Children’s Health, adult specialty care, urgent care and other services needed in the region for the entire family.
UCI receives record $529 million in research funding for fiscal 2019-20
Irvine, Calif., July 20, 2020 — From cutting-edge research and clinical trials focused on cancer care to creating a new center devoted to protecting personal data privacy, University of California, Irvine scholars, scientists and physicians are blazing new paths to help change the world. And their impact keeps growing. In fiscal 2019-20, which ended June 30, UCI researchers received the most funding in campus history: $529 million in grants and contracts.
Caution urged for reopening schools to prevent spread of COVID-19 crisis
Irvine, Calif., June 15, 2020 — With fast-approaching preparations required for a new school year with no consensus plan yet in place, a team of clinicians, scientists and educators – including a University of California, Irvine pediatrician – stress the need for caution when re-opening America’s schools and advocate for large-scale viral testing in children, contract tracing and other actions to avoid compounding the COVID-19 crisis.
UCI to take part in clinical trial of drug for critically ill COVID-19 patients
Orange, Calif., May 13, 2020 — UCI Health will initiate a clinical study of a drug to treat critically ill COVID-19 patients who face a high mortality rate because of acute inflammation that fills their lungs with fluid, a grave condition that even mechanical ventilation cannot improve. Aviptadil, which has a 20-year history of use in human clinical trials for lung ailments, will be employed in a phase 2b/3 clinical study of COVID-19 patients suffering from acute respiratory distress syndrome, a primary cause of coronavirus-induced death, said Dr.
Tu Foundation gives $2.5 million to UCI to support COVID-19 patient care, research
Irvine, Calif., May 11, 2020 — A $2.5 million gift from the John and Mary Tu Foundation to the University of California, Irvine is supporting COVID-19-associated patient care at UCI Health and advance clinical and translational research across campus focused on new ways to test for and treat the viral infection. As the region’s only combined academic health system and public research university, UCI is at the forefront in galvanizing an active response to the pandemic.